Search

Your search keyword '"Lambadiari V"' showing total 338 results

Search Constraints

Start Over You searched for: Author "Lambadiari V" Remove constraint Author: "Lambadiari V"
338 results on '"Lambadiari V"'

Search Results

2. Effects of sodium-glucose contrasporter-2 inhibitors and glucagon-like peptide-1 receptor agonists on vascular function and liver steatosis in diabetes

3. Association of GDF15, NTpoBNP and PLGF with subclinical cardiac dysfunction in type 2 diabetes: effects of novel antidiabetic treatment

4. Longitudinal myocardial deformation and its improvement after treatment has an additive prognostic value to SCORE2 in psoriasis: a 4-year follow-up study

6. Olive extract enriched with hydroxytyrosol improves cardiac and vascular function in patients with stable coronary artery disease: a double-blind, placebo-controlled trial

7. Effect of glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors and their combination on markers of neurohumoral activation and left atrial strain

8. Association of fatty liver with left ventricular concentric remodeling: Insights from the Corinthia study

10. Metabolic syndrome and atherosclerotic cardiovascular disease in non-diabetic adult patients with familial hypercholesterolemia: Data from the Hellas-FH registry

11. Triglycerides and atherosclerotic cardiovascular disease in adult patients with familial hypercholesterolemia: Data from the Hellas-FH registry

12. Overweight/obesity and prevalent atherosclerotic cardiovascular disease in patients with heterozygous familial hypercholesterolemia: An analysis from HELLAS-FH registry

13. One year follow-up of cardiovascular profile and therapeutic management of children and adolescents with familial hyphercholesterolemia: Preliminary data from the Hellas-FH registry

14. Differences in coronary flow reserve and flow-mediated dilation between plaque psoriasis and psoriatic arthritis

16. SARS-CoV-2 is associated withabnormal biomarkers of oxidative stress,and endothelial function linked with cardiovascular dysfunction four months after the infection

17. Four-month treatment with long-acting glucagon-like peptide-1 receptor agonists (GLP-1) or sodium-glucose co-trasporter-2 inhibitors (SGLT-2i) improves vascular function in type 2 diabetes mellitus

18. Differences in Left atrial stain, endothelial glycocalyx, arterial elasticity and myocardial efficiency between ESUS, lacunar and atherosclerotic type of stroke

20. Impaired endothelial glycocalyx, vascular dysfunction and myocardial deformation four months after COVID-19 infection are partially improved at twelve months

21. Endothelial dysfunction due to decreased nitric oxide bioavailability in dysglycaemic subjects and first-degree relatives of type 2 diabetic patients

22. Biologics improve endothelial, vascular and left ventricular myocardial function in patients with psoriatic arthritis

24. One year follow-up of patients with familial hypercholesterolemia: Preliminary data from the HELLAS-FH registry

25. Association between lipoprotein(a) concentrations and atherosclerotic cardiovascular disease risk in patients with familial hypercholesterolemia: An analysis from the hellas-fh

26. Association of TG/HDL-C and TYG indices with the prevalence of atherosclerotic cardiovascular disease in adult patients with familial hypercholesterolemia

27. The role of acetic acid on glucose uptake and blood flow rates in the skeletal muscle in humans with impaired glucose tolerance

28. Prevalence and Prognostic Factors of Stress Hyperglycemia in a Pediatric Population with Acute Illness in Greece—A Prospective Observational Study

29. The Impact of Laboratory Findings and Optical Coherence Tomography Biomarkers on Response to Intravitreal Anti-VEGF Treatment in Patients with Diabetic Macular Edema

30. Type 2 Diabetes Mellitus as a Risk Factor for Alzheimer’s Disease: Review and Meta-Analysis

31. Association between lipoprotein(a) concentrations and atherosclerotic cardiovascular disease risk in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH

32. Left Atrial Deformation in Heart Failure: A Clinical Update

33. Cardioprotection by selective SGLT-2 inhibitors in a non-diabetic mouse model of myocardial ischemia/reperfusion injury: a class or a drug effect?

34. Cost-Effectiveness Analysis of an Advanced Hybrid Closed-Loop Insulin Delivery System in People with Type 1 Diabetes in Greece

35. Early arrhythmia recurrence after cryoballoon ablation in atrial fibrillation: A systematic review and meta-analysis

36. Apremilast Improves Endothelial Glycocalyx Integrity, Vascular and Left Ventricular Myocardial Function in Psoriasis

37. Association of COVID-19 with impaired endothelial glycocalyx, coronary flow and longitudinal strain four months after infection

38. Association of COVID-19 with impaired endothelial glycocalyx, vascular function and myocardial efficiency four months after infection

39. Differences in Left atrial stain, endothelial glycocalyx and arterial elasticity between ESUS, lacunar and atherosclerotic type of stroke

40. The combination of dulaglutide and dapagliflozin improves arterial stiffness, endothelial glycocalyx and albuminuria vs DPP-4 inhibitors independently of glycemic control

41. Effect ofglucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors and their combination on left atrial strain and arterial function

42. Apremilast improves endothelial glycocalyx and microvascular perfusion: a possible protective mechanism against COVID-19

43. COVID-19 patients present impaired endothelial glycocalyx, vascular dysfunction and myocardial deformation resembling those observed in hypertensives four months after infection

44. Differences in left atrial stain, endothelial glycocalyx and arterial elasticity between ESUS, lacunar and atherosclerotic type of stroke

45. Endothelial glycocalyx integrity and microvascular perfusion are associated with novel echocardiographic markers and carotid intima-media thickness in patients with psoriasis

46. Impaired endothelial glycocalyx predicts adverse outcome in subjects without overt cardiovascular disease: a 6-year follow-up study

47. The midterm differential effects of heat-not-burn and conventional cigarettes on coronary flow, vascular function and oxidative stress are independent of nicotine levels

48. First-degree relatives of type-2 diabetic patients and dysglycaemic patients have impaired endothelial function due to decreased bioavailability of nitric oxide

49. The effect of one year treatment with GLP1-RA, SGLT2i and their combination on plasma levels of oxidative and antioxidative biomarkers

Catalog

Books, media, physical & digital resources